MCHP
Microchip Technology Incorporated
MCHP has slightly lower modeled downside risk, despite its lower overall score.
MU
Micron Technology, Inc.
MU has the edge over MCHP overall, supported by stronger valuation and stronger fundamentals.
MCHP Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Stable |
MCHP's revenue, profitability and cash flow are currently strong, and its balance sheet is stable.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
MCHP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 15x | $62.08 | — |
| Cheap | 21x | $28.42 | -54% |
| Fair | 40x | $53.17 | -14% |
| Current | 47x | $62.08 | — |
| Expensive | 104x | $138 | +122% |
Historical ranges are pointers, not guarantees.
MCHP's PE is in its fair range at 47x. If earnings grow as analysts expect, today's price would be 15x next year's earnings, in its cheap range.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU has the edge over MCHP in the historical PE scenario, which offers more potential upside but is not a forecast.
MCHP Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for MCHP, with profitability improving.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for MU, with profitability improving.
MCHP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.02 | +202% |
| Q3 2026 | $1.33 | +$1.78 |
| Q2 2026 | $0.68 | +$1.02 |
| Q1 2026 | $0.22 | +$0.23 |
| Q4 2025 | -$0.29 | -151% |
| Q3 2025 | -$0.45 | -131% |
| Q2 2025 | -$0.34 | -114% |
| Q1 2025 | -$0.01 | -100% |
| Q4 2024 | $0.57 | -87% |
MCHP has returned to profit: it earned $1.33 per share over the past year, after losing money the year before.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over MCHP on earnings, with more consistent year-over-year improvement.
MCHP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +42% |
| Q2 2026 | $1.5B | +38% |
| Q1 2026 | $1.3B | +35% |
| Q4 2025 | $1.2B | +16% |
| Q3 2025 | $1.1B | -2% |
| Q2 2025 | $1.1B | -13% |
| Q1 2025 | $970.5M | -27% |
| Q4 2024 | $1B | -42% |
MCHP's revenue is recovering but still below its 2023 peak: $1.6B last quarter, up 42% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 29% | +21 points |
| Q2 2026 | 23% | +20 points |
| Q1 2026 | 17% | +27 points |
| Q4 2025 | 13% | +9.8 points |
| Q3 2025 | 7.8% | -4.8 points |
| Q2 2025 | 3% | -15 points |
| Q1 2025 | -10% | -30 points |
| Q4 2024 | 3% | -27 points |
MCHP's operating margin was 29% last quarter, up 21 points from the same quarter a year ago.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over MCHP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over MCHP on profitability, with a higher operating margin.
MCHP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $396.1M | +668% |
| Q2 2026 | $497.6M | +93% |
| Q1 2026 | $242.8M | +27% |
| Q4 2025 | $318.9M | +26% |
| Q3 2025 | $51.6M | +126% |
| Q2 2025 | $257.7M | -15% |
| Q1 2025 | $191.7M | -51% |
| Q4 2024 | $253.4M | -68% |
MCHP's free cash flow has been positive every quarter for seven years: $1.5B over the past year, up 93% from the year before.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over MCHP on cash flow, with more consistent year-over-year improvement.
MCHP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +100K shares |
| 1 year | +1% | +5.6M shares |
| 3 years | +0.3% | +1.4M shares |
| 5 years | -2.7% | -15.3M shares |
| Available history | +6.6% | +34M shares |
MCHP has the edge over MU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $6.5M |
| Q3 2024 | $17.3M |
| Q2 2024 | $72.7M |
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has 1.1B diluted shares, up 1.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
MCHP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.8x | Moderate |
| Q2 2026 | 3.5x | Elevated |
| Q1 2026 | 4.5x | High |
| Q4 2025 | 5.9x | High |
| Q3 2025 | 6.7x | High |
| Q2 2025 | 5.8x | High |
| Q1 2025 | 4.6x | High |
| Q4 2024 | 4.3x | High |
MCHP's net debt is about 2.8 years of its operating earnings (EBITDA), down from 6.7 years a year ago.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has the edge over MCHP on leverage, with a lower net debt burden relative to earnings.
MCHP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 28.2 | Neutral |
MCHP's weekly RSI is 39 (neutral) and its Stochastic is 28 (neutral).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
MCHP PE vs Technology Sector
| Metric | MCHP | Sector median | Relative |
|---|---|---|---|
| PE | 47x | 28x | 68% above |
| PE % | 61 | 35 | 26 pts above |
MCHP is trading at 47x earnings, a 68% premium to the Technology sector's median of 28x.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over MCHP on valuation relative to its sector.
MCHP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $72.7 | 15% below |
| 20 week MA | $76.2 | 18% below |
| 50 week MA | $77.2 | 20% below |
| 100 week MA | $68.2 | 9% below |
| 200 week MA | $75.2 | 17% below |
MCHP is in a downtrend: it's below all five of its weekly moving averages, and 17% below its 200-week average.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has the edge over MCHP on trend strength, trading above more of its moving averages.
MCHP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $52.7 | $68.4 | +30% |
| 2021 | $68.4 | $86.9 | +27% |
| 2022 | $86.9 | $69.9 | -20% |
| 2023 | $69.9 | $90.2 | +29% |
| 2024 | $90.2 | $58.3 | -35% |
| 2025 | $58.3 | $64.9 | +11% |
| 2026 YTD | $64.9 | $62.1 | -4.4% |
MCHP has finished higher in four of the last six years. It's down 4.4% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over MCHP on returns for 2026, with the stronger performance.